Good Response With Nivolumab Plus Axitinib in Metastatic RCC
Combination treatment with nivolumab plus axitinib has achieved a high response rate in...
Read MoreFeb 23, 2022
Combination treatment with nivolumab plus axitinib has achieved a high response rate in...
Read MoreFeb 23, 2022
Biomarker analysis of the phase 2 TITAN-RCC trial identified specific immune cell-related...
Read MoreFeb 23, 2022
Results of the NeoAvAx trial indicate that the neoadjuvant combination of avelumab plus axitinib...
Read MoreFeb 23, 2022
In order to successfully navigate the ins and outs of necessities like insurance, technology...
Read MoreFeb 22, 2022
In early February, two senators introduced the Telehealth Extension and Evaluation Act to extend Medicare telehealth reimbursement waivers another 2 years following the end of the public health emergency declared due to the COVID pandemic.
Read MoreFeb 14, 2022
The purpose of the “Love Your Liver” (#LoveYourLiver) campaign is to educate the public and...
Read MoreFeb 14, 2022
Imagine for a moment the trauma a parent experiences when burying their child. This is an...
Read MoreFeb 14, 2022
Olfactory dysfunction (OD) can have important effects on QOL for patients and serves as a...
Read MoreFeb 11, 2022
Preoperative PET/CT provided information on standardized uptake value (SUV) and volumetric...
Read MoreFeb 10, 2022
A dose-response relevance was observed between levels of allergen-specific IgE and allergic...
Read MoreFeb 3, 2022
Most people don’t know the history of barbershops and health. A brief review of the literature...
Read MoreFeb 3, 2022
Hyperuricemia (HU) has been identified as an important predictor in the development of gout....
Read MoreFeb 1, 2022
The incidence of novel asymptomatic, or silent, lesions during remission are uncommon in myelin...
Read MoreFeb 1, 2022
A study published in the European Urology Oncology reports superior oncologic and safety benefits of adjuvant pembrolizumab compared with adjuvant tyrosine kinase inhibitors (TKIs) in patients treated with nephrectomy for...
Read MoreJan 31, 2022
Contributor Ted R. Mikuls, MD, MSPH, Umbach Professor of Rheumatology, Vice Chair for Research,...
Read MoreJan 26, 2022
It’s nearly impossible to avoid screen time these days; between smartphones, TVs, computers, and...
Read MoreJan 26, 2022
The presence of cardiovascular disease (CVD) comorbidities and type 2 diabetes (T2D) increased the...
Read MoreJan 24, 2022
The COVID-19 pandemic has proven to be especially traumatic for the elderly and those with chronic...
Read MoreJan 20, 2022
While most of us are now used to wearing face masks and social distancing, life during the...
Read MoreJan 20, 2022
Women with advanced/recurrent endometrial cancer, especially those with the non-endometrioid (type...
Read More